The prevalence of MEFV mutations in Egyptian children with juvenile systemic lupus / Nora Nazar Abdelaziz ; Supervised Samia Salah Eldin Mahmoud , Hala Mohamed Lotfy , Samar Mohamed Sabry
Material type:
- عند الأطفال المصريين المصابين بمرض الذئبة الحمراء MEFV معدل إنتشار التحور الجينى فى جين [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.28.M.Sc.2018.No.P (Browse shelf(Opens below)) | Not for loan | 01010110077886000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.28.M.Sc.2018.No.P (Browse shelf(Opens below)) | 77886.CD | Not for loan | 01020110077886000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics
Background and aim: Familial mediterranean fever and systemic lupus erythematosus are both chronic diseases with common symptoms. Familial mediterranean fever is the most common auto-inflammatory monogenic disease affecting people of the Mediterranean basin. Systemic lupus is a chronic multisystem autoimmune connective tissue disorder that manifests itself with different phenotypes. It has been observed in the rheumatology clinic at Abu Reesh Hospital that the incidence of Juvenile SLE is more common than previously believed. The aim of the study was to investigate the frequency and clinical significance of MEFV mutations in Egyptian children with SLE. Finding an association between SLE and FMF in Egyptian children may lead to a change in the treatment regimens of the patients and the criteria of diagnosis for Egyptian SLE patients and therefore better disease outcome. Methods: The study enrolled 60 children diagnosed with systemic lupus, together with 30 sex-and age-matched apparently healthy controls. The entire study group was screened for the 12 most common MEFV mutations using reverse hybridization assay of biotinylated PCR products. Results: SLE patients had a significantly higher frequency of MEFV mutations (76.7%) than in the healthy control population (30%). V726A was the leading mutation in SLE patients, with allele frequency of 52.2%, followed by E148Q with allele frequency of 23.9%. While in the control group, the leading allele frequency was E148Q and V726A 13.3% each
Issued also as CD
There are no comments on this title.